Variables | Total QoL | p value | Physical health | p value | Pain | p value | Planning | p value | Intimate relationship | p value | Burden to others | p value | Emotional health | p value | Body image | p value | Fatigue | p value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cognitive Impairment* | ||||||||||||||||||
 Yes | 80.35 (65.67–85.83) | 0.750 | 81.20 (68.75–90.62) | 0.200 | 83.3 (66.60–91.60) | 0.500 | 83.3 (75–100) | 0.120 | 100 (75–100) | 0.890 | 75 (50–91.60) | 0.410 | 79.10 (54.10–87.50) | 0.730 | 85 (50–100) | 0.880 | 75 (56.25–87.50) | 0.810 |
 No | 77.25 (65.42–88.48) | 78.10 (68.72–85.83) | 75 (67.65–87.45) | 91.66 (75–100) | 100 (75–100) | 75 (50–91.60) | 75 (62.50–91.63) | 80 (70–94) | 75 (56.25–87.50) | |||||||||
Anxiety* | ||||||||||||||||||
 Yes | 65.33 (50.77–77.18) | < 0.001*** | 70.27 (62.50–80.42) | < 0.001*** | 75 (52.07–83.30) | < 0.001*** | 75 (58.30–91.60) | < 0.001*** | 75 (56.25–100) | 0.001*** | 50 (27.07–75) | < 0.001*** | 58.3 (37.50–75) | < 0.001*** | 72.5 (46.25–85) | < 0.001*** | 62.25 (89.06–75) | < 0.001*** |
 No | 84.20 (76.85–89.24) | 84.37 (75–90.62) | 83.30 (75–91.82) | 91.66 (83.30–100) | 100 (87.35–100) | 83.3 (75–98.67) | 83.3 (75–93.30) | 90 (75–100) | 75 (62.50–87.50) | |||||||||
Depression* | ||||||||||||||||||
 Yes | 63.22 (47.02–83.74) | 0.003*** | 70.27 (52.34–80.42) | 0.008*** | 70.8 (41.60–89.52) | 0.013*** | 75 (54.15–91.60) | 0.004*** | 75 (40.62–100) | 0.003*** | 50 (27.07–81.22) | 0.007*** | 60.4 (34.45–86.50) | 0.021*** | 72.5 (28.75–93.75) | 0.041*** | 68.75 (40.62–87.50) | 0.373 |
 No | 81.06 (71.11–87.20) | 82.22 (69.51–90.60) | 75 (75–91.60) | 91.6 (75–100) | 100 (75–100) | 75 (58.30–91.64) | 79.16 (70.80–90.57) | 85 (70–100) | 75 (62.12–81.62) | |||||||||
Disease duration** | r 0.24 | 0.011*** | r 0.14 | 0.132 | r 0.11 | 0.249 | r 0.10 | 0.298 | r 0.12 | 0.249 | r 0.24 | 0.011*** | r 0.28 | 0.003*** | r 0.20 | 0.034*** | r 0.25 | 0.070 |
Age** | r 0.18 | 0.058 | r 0.22 | 0.018*** | r 0.12 | 0.196 | r 0.03 | 0.752 | r –0.19 | 0.043*** | r 0.37 | < 0.001*** | r 0.29 | 0.002*** | r 0.19 | 0.045*** | r 0.19 | 0.042*** |
Disease activity** | r -0.15 | 0.117 | r -0.10 | 0.266 | r -0.10 | 0.299 | r -0.08 | 0.378 | r 0.07 | 0.427 | r -0.13 | 0.160 | r -0.22 | 0.016*** | r -0.18 | 0.060 | r -0.21 | 0.022*** |
Comorbidities* | ||||||||||||||||||
 Yes | 81.51 (62.44–88) | 0.680 | 78.10 (75–91.60) | 0.731 | 75 (58.30–91.60) | 0.342 | 83.30 (75–100) | 0.691 | 100 (75–100) | 0.468 | 75 (54.15–93.20) | 0.133 | 83.30 (54.15–91.68) | 0.377 | 90 (75–100) | 0.210 | 75 (56.22–87.50) | 0.807 |
 No | 77.99 (65.67–86.75) | 78.10 (68.70–87.50) | 75 (75–91.60) | 91.60 (75–100) | 100 (75–100) | 75 (41.60–83.30) | 75 (62.50–87.50) | 80 (65–95) | 75 (56.25–87.50) | |||||||||
Steroid dose** | r -0.10 | 0.291 | r -0.06 | 0.541 | r -0.11 | 0.236 | r -0.12 | 0.213 | r 0.04 | 0.710 | r -0.09 | 0.332 | r -0.15 | 0.102 | r -0.18 | 0.051 | r -0.14 | 0.120 |
Immunosuppressant medication* | ||||||||||||||||||
Hydroxychloroquine | ||||||||||||||||||
 Yes | 80.86 (65.40–86.75) | 0.790 | 78.12 (68.75–90.60) | 0.671 | 75 (66.60–91.60) | 0.878 | 83.70 (75–100) | 0.711 | 100 (75–100) | 0.682 | 75 (41.60–91.60) | 0.860 | 75 (41.60–91.60) | 0.447 | 80 (65–100) | 0.530 | 70 (56.25–87.50) | 0.386 |
 No | 78.16 (69.56–87.76) | 78.10 (68.75–87.50) | 75 (75–87.45) | 91.60 (75–100) | 100 (75–100) | 75 (50.36–91.60) | 75 (50.36–91.60) | 85 (75–95) | 75 (62.50–87.50) | |||||||||
Mycophenolate mofetil | ||||||||||||||||||
 Yes | 76.40 (54.52–85.49) | 0.073 | 78.10 (68.75–87.50) | 0.471 | 75 (58.30–91.60) | 0.139 | 83.30 (75–100) | 0.098 | 100 (75–100) | 0.778 | 75 (50–83.30) | 0.228 | 75 (55.15–86.50) | 0.173 | 75 (41.25–90) | 0.008*** | 68.77 (51.56–81.25) | 0.169 |
 No | 81.49 (67.93–88.35) | 78.11 (68.75–90.60) | 78.10 (68.75–87.50) | 91.60 (75–100) | 100 (75–100) | 75 (43.70–91.67) | 79.16 (66.60–91.64) | 87.50 (75–100) | 75 (60.62–87.50) | |||||||||
Azathioprine | ||||||||||||||||||
 Yes | 78.16 (65.44–89.70) | 0.573 | 78.10 (65.60–90.62) | 0.866 | 91.60 (75–91.70) | 0.072 | 100 (75–100) | 0.351 | 100 (75–100) | 0.334 | 75 (33.33–91.60) | 0.845 | 75 (58.30–87.50) | 0.275 | 90 (70–95) | 0.299 | 75 (56.25–87.50) | 0.744 |
 No | 80 (65.53–86.77) | 78.10 (68.75–89.05) | 75 (66.60–90.62) | 83.3 (75–100) | 100 (75–100) | 75 (50–91.60) | 79.10 (62.50–89.55) | 80 (65–100) | 75 (56.25–84.62) | |||||||||
Methotrexate | ||||||||||||||||||
 Yes | 64.73 (51.56–86.28) | 0.257 | 68.70 (60.93–87.50) | 0.179 | 66.85 (37.52–81.25) | 0,175 | 75 (64.52–93.70) | 0.221 | 77 (18.75–100) | 0.136 | 79.15 (37.45–100) | 0.629 | 77.05 (36.45–87.50) | 0.866 | 77.5 (52.50–85) | 0.399 | 59.35 (40.62–82.77) | 0.254 |
 No | 80.18 (65.72–87.09) | 78.10 (68.75–90.60) | 75 (66.69–91.60) | 91.60 (75–100) | 100 (75–100) | 75 (50–91.60) | 79.05 (61.45–87.50) | 85 (65–100) | 75 (56.25–87.50) | |||||||||
Cyclosporine | ||||||||||||||||||
 Yes | 88.16 (73.50–89.24) | 0.212 | 78.11 (73.37–89.84) | 0.660 | 79.15 (75–95.82) | 0.500 | 91.65 (77.07–100) | 0.521 | 100 (81.25–100) | 0.457 | 83.30 (39.57–95.82) | 0.522 | 83.33 (75–93.94) | 0.426 | 85 (76.25–90) | 0.963 | 81.25 (75–87.50) | 0.181 |
 No | 79.19 (65.41–86.62) | 78.10 (68.75–89.82) | 75 (66.61–91.60) | 87.65 (75–100) | 100 (75–100) | 75 (50–91.60) | 79.05 (58.30–87.50) | 85 (65–100) | 75 (56.25–86.06) | |||||||||
Organ involvement* | ||||||||||||||||||
Musculoskeletal | ||||||||||||||||||
 Yes | 80.18 (65.61–87.13) | 0.387 | 78.10 (68.70–90.60) | 0.738 | 75 (66.64–91.60) | 0.917 | 83.31 (75–100) | 0.727 | 100 (75–100) | 0.030*** | 75 (50–91.60) | 0.212 | 79.10 (5.30–91.60) | 0.375 | 82.50 (65–100) | 0.680 | 75 (56.25–87.50) | 0.438 |
 No | 73.70 (62.93–84.29) | 82.77 (65.55–87.12) | 75 (70.82–93.74) | 91.60 (75–100) | 75 (43.75–100) | 62.50 (25–79.15) | 75 (68.72–80.19) | 87.50 (78–95) | 66.25 (54.65–76.56) | |||||||||
Mucocutaneous | ||||||||||||||||||
 Yes | 79.75 (65.42–86.94) | 0.519 | 78.10 (68.75–89.05) | 0.766 | 75 (66.68–91.60) | 0.706 | 91.60 (75–100) | 0.556 | 100 (75–100) | 0.821 | 75 (50–83.30) | 0.288 | 79.10 (58.30–87.50) | 0.305 | 80 (65–95) | 0.156 | 75 (56.25–84.62) | 0.794 |
 No | 81.51 (68.98–92.31) | 75 (62.50–90.62) | 75 (58.30–100) | 83.30 (75–100) | 87.50 (75–100) | 91.60 (33.30–100) | 75 (75–100) | 95 (75–100) | 75 (50–87.50) | |||||||||
Renal | Â | |||||||||||||||||
 Yes | 81.34 (70.80–87.17) | 0.431 | 78.10 (68.75–90.60) | 0.957 | 75 (75–91.66) | 0.275 | 83.30 (75–100) | 0.923 | 100 (75–100) | 0.121 | 75 (56.40–91.60) | 0.836 | 79.13 (73.95–88.52_ | 0.630 | 82.50 (68.75–95) | 0.743 | 75 (56.25–87.50) | 0.463 |
 No | 78.39 (65.06–86.87) | 78.11 (68.75–88.27) | 75 (58.60–91.60) | 91.60 (75–100) | 100 (75–100) | 75 (41.60–91.61) | 77 (54.14–88.52) | 85 (65–100) | 82.50 (68.75–95) | |||||||||
Hematology | ||||||||||||||||||
 Yes | 83.50 (65.22–88.79) | 0.577 | 75 (65.60–87.50) | 0.637 | 83.30 (75–91.70) | 0.227 | 91.60 (75–100) | 0.791 | 100 (75–100) | 0.638 | 75 (33.33–91.60) | 0.685 | 75 (58.33–87.50) | 0.221 | 88 (70–95) | 0.637 | 70 (56.26–87.50) | 0.863 |
 No | 78.58 (65.56–85.88) | 78.10 (68.75–90.60) | 75 (66.60–83.30) | 83.33 (75–100) | 100 (75–100) | 75 (50–91.60) | 79.16 (60.40–91.63) | 80 (65–100) | 75 (56.25–81.25) | |||||||||
Neuropsychiatric | ||||||||||||||||||
 Yes | 80 (50,49–88,28) | 0,452 | 75 (65.60–90.60) | 0.523 | 83.30 (50–91.60) | 0.858 | 83.30 (66.60–100) | 0.365 | 87.50 (37.50–100) | 0.086 | 75 (41.60–91.60) | 0.732 | 75 (45.80–91.60) | 0.190 | 85 (55–100) | 0.972 | 70 (56.25–87.50) | 0.884 |
 No | 79,75 (67,07–86,77) |  | 78.10 (68.75–89.05) |  | 75 (66.68–91.60) |  | 91.60 (75–100) |  | 100 (75–100) |  | 75 (50–91.60) |  | 79.16 (67.05–87.50) |  | 85 (67.50–97.50) |  | 75 (56.25–84.62) |  |
Education level* | ||||||||||||||||||
 Primary | 81.51 (59.05–91.16) | 0.160 | 81.20 (65.62–90.61) | 0.806 | 83.30 (66.65–95.93) | 0.245 | 91.60 (75–100) | 0.690 | 100 (75–100) | 0.978 | 75 (70.80–91.65) | 0.210 | 83.30 (75–93.70) | 0.110 | 90 (72.50–100) | 0.083 | 81.20 (65.62–93.72) | 0.138 |
 Secondary | 77.48 (61.23–85.83) |  | 78.10 (68.70–90.60) |  | 75 (58.60–83.30) |  | 83.50 (75–100) |  | 100 (75–100) |  | 75 (41.60–83.30) |  | 75 (48.95–84.37) |  | 77.50 (48.75–95) |  | 68.72 (50–81.37) |  |
 Tertiary | 81.05 (66.83–89.02) |  | 78.10 (70.27–87.50) |  | 83.30 (70.85–91.63) |  | 83.33 (75–100) |  | 100 (75–100) |  | 75 (58.30–93.2) |  | 75 (67.05–91.60) |  | 90 (72.50–100) |  | 75 (61–87.50) |  |